Latest Artificial Intelligence News

InteliCare Holdings has raised $2 million through a two-tranche placement to accelerate its AI-driven aged care platform and terminated a convertible note facility to streamline its capital base.

WhiteHawk Limited and DoxAI have forged a three-year strategic partnership to integrate AI-driven automation with advanced cyber risk and compliance solutions, aiming to accelerate digital transformation across key sectors in North America and Australia.

4DMedical confirms its partnership with AstraZeneca in Brazil and announces a new contract supporting Australia’s National Lung Cancer Screening Program, signaling strategic growth in respiratory imaging.

InFocus Group Holdings has locked in up to AUD 1.7 million in potential revenues through new contracts in healthcare and logistics, underpinning its operational expansion in Southeast Asia.

Spark New Zealand has launched its ambitious SPK-30 strategy, refocusing on core connectivity services with heavy investment in 5G and AI-driven customer experiences. The plan aims to deliver stable returns and sustainable growth amid evolving market dynamics.

Carnegie Clean Energy has successfully raised $2.116 million through a Share Purchase Plan, fueling key wave energy projects and global business development efforts.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

FirstWave Cloud Technology has completed a $1.6 million annual restructure aimed at driving growth through AI-powered compliance management and monetising its large free user base.

Imagion Biosystems has reached key milestones in its MagSense® HER2 breast cancer imaging program, including starting manufacturing for its Phase 2 trial and launching an AI imaging protocol collaboration with Wayne State University.

SenSen Networks has secured $2 million in new contracts across Singapore, the USA, and Australia, reinforcing its position as a leader in Live Awareness AI solutions. The company also strengthened its balance sheet with $1.5 million cash received from a recent Montreal project.

4DMedical has secured multi-year agreements to deploy its advanced lung imaging technology across Brazil and Australia, supporting national lung cancer screening programs and enhancing lung health diagnostics.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.